# Selection of Allogeneic Hematopoietic Cell Donors Based on KIR and HLA Genotypes

> **NCT02450708** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 511 (actual)

## Conditions studied

- Leukemia

## Interventions

- **GENETIC:** KIR genotyping
- **GENETIC:** HLA genotyping

## Key facts

- **NCT ID:** NCT02450708
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2015-05
- **Primary completion:** 2026-05
- **Final completion:** 2026-05
- **Target enrollment:** 511 (ACTUAL)
- **Last updated:** 2025-06-29

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02450708

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02450708, "Selection of Allogeneic Hematopoietic Cell Donors Based on KIR and HLA Genotypes". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02450708. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*